$1.08
1.89%
Nasdaq, Aug 22, 10:24 pm CET
ISIN
IL0011814113
Symbol
PLRZ

Polyrizon Stock price

$1.08
-0.37 25.52% 1M
-236.42 99.55% 6M
-541.42 99.80% YTD
-386.42 99.72% 1Y
-386.42 99.72% 3Y
-386.42 99.72% 5Y
-386.42 99.72% 10Y
-386.42 99.72% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.02 1.89%
ISIN
IL0011814113
Symbol
PLRZ
Industry

Key metrics

Basic
Market capitalization
$6.4m
Enterprise Value
$3.8m
Net debt
positive
Cash
$2.6m
Shares outstanding
20.0k
Valuation (TTM | estimate)
P/E
negative | -
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
1.2
Financial Health
Equity Ratio
95.3%
Return on Equity
-30.4%
ROCE
-31.2%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | -
EBITDA
$-1.5m | -
EBIT
$-1.6m | -
Net Income
$-2.2m | -
Free Cash Flow
$-1.2m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-186.4
FCF per Share
$-57.4
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Polyrizon a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Financial data from Polyrizon

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 0.98 0.98
-
-
- Research and Development Expense 0.67 0.67
-
-
-1.53 -1.53
-
-
- Depreciation and Amortization 0.12 0.12
-
-
EBIT (Operating Income) EBIT -1.65 -1.65
-
-
Net Profit -2.23 -2.23
-
-

In millions USD.

Don't miss a Thing! We will send you all news about Polyrizon directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Polyrizon Stock News

Neutral
GlobeNewsWire
11 days ago
Ra'anana, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced that it has received formal confirmation from the Hearings Advisor (the “Hearings Advisor”) of the Office of the General Counsel of the Nasdaq Hearings Panel (the “Nasdaq Hearings Panel”) of ...
Neutral
GlobeNewsWire
about one month ago
Ra'anana, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced encouraging preclinical results supporting the performance of its PL-14 Allergy Blocker, part of its proprietary Capture & Contain (C&C) platform. The study, conducted in collaboration with t...
Neutral
GlobeNewsWire
about one month ago
Raanana, Israel, July 15, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a notification letter from the Nasdaq Hearings Panel (the “Panel”) granting the Company's request for the continued listing of its securities on the ...
More Polyrizon News

Company Profile

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Head office Israel
CEO Tomer Izraeli
Founded 2005
Website polyrizon-biotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today